Adding a certain compound to certain chemical reactions, such as: 5334-39-4, name is 3-Methyl-4-nitro-1H-pyrazole, belongs to pyrazoles-derivatives compound, can increase the reaction rate and produce products with better performance than those obtained under traditional synthetic methods. Here is a downstream synthesis route of the compound 5334-39-4, COA of Formula: C4H5N3O2
To a solution of cw-3-benzyloxycyclobutanol (17 g, 95 ,4 mmol) and 3-methyl-4-nitro-lH-pyrazole (12.1 g, 95.4 mmol) in THF (350 mL) was added PPh3 (37.5 g, 143 mmol). Then, DIAD (28.9 g, 143 mmol) was added slowly at 0 C, and the mixture was stirred at 15 C for 20 h. The mixture was quenched with H2Q (100 mL), then filtered. The filtrate was then extracted with EtOAc (3 x 70 mL), The organic phase was washed with brine (30 mL), dried over anhydrous Na2S04, filtered and concentrated. The residue was purified by silica gel colum chromatography (PE:EtOAc = 10: 1 to 7: 1), to give trans- l-(3-benzyloxycyclobutyl)-5-methyl-4-nitro-pyrazole and trans-l-(3- benzyloxycyclobutyl)-3-methyl-4-nitro-pyrazoleTo a solution of /ra>v-l-(3-benzyloxycyclobutyl)-5-methyl-4-nitro-pyrazole and rra?is-l-(3-benzyloxyxyck)butyl)-3-methyl-4-nitro-pyrazole (19.5 g, 67.9 mmol) in DCM (200 mL) was added BC1 (1 M, 26.5 mL) at 0 C, and the mixture was stirred at 0 C for 2 h. The mixture was poured into water (200 mL) slowly, then extracted with DCM (2 x 100 mL). The organic phase was washed with aqueous ai K ()·. (50 mL), brine (40 mL), dried over anhydrous Na2S04, filtered and concentrated. The residue was purified by silica gel column chromatography (PE/EtOAc = 2 : 1 to 1 : 1), to give trans-3-[5- methyi-4-nitro-pyrazol- 1 -yl]cyclobutanol and trans-3-[3-methyl-4-nitro-pyrazol-1-yl]cyclobutanol as a mixture as a white soli d . To a mixture of trans-3~[5-methyl-4-nitro- pyrazol- 1 -yl] cyclobutanol and rrav-3-[3-methyl-4-nitro-pyrazol-l-yl]cyclobutanol ( 1.4 g, 7.1 mmol) in CL CN (100 mL) was added Cul (541 mg, 2.84 mmol) and 2,2-difluoro-2-fluorosulfonyl-acetic acid ( 1.9 g, 10.65 mmol) at 15 C, and the mixture was stirred at 55 C for 2 h. The mixture was quenched with water (5 mL), The solvent was filtered through celite and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (PE: EtOAc = 10: 1), to give trans- 1 – [3 -(difluoromethoxy)cyciobutyl] -5 -methy 1-4-nitr o-pyrazole and trans- 1-[3- (difluoroinethoxy)cyclobutyi]~3-methyl-4-nitro~pyrazole as a yellow solid To a mixture of ras-l-[3- (difiuoi methoxy)cyclobutyl |-5~methyl-4″nitro-pyrazoie and ro;/s~l~[3-(difluoromethoxy)cyclobutyl]-3- methyl-4-nitro-pyrazole (350 mg, 1.42 mmol) and NH4CI (379 mg, 7.08 mmol) in EtOH (8,8 mL) and H20 (2.2 mL) was added powder Fe (395 mg, 7.08 mmol) at 15 C, then the mixture was stirred at 80 C for 2 h. The mixture was filtered through celite, and the filtrate was concentrated under reduced pressure. The mixture was extracted with EtOAc (2 x 30 mL). The organic phase was washed with brine (10 mL), dried over anhydrous Na2S04, filtered and concentrated to give trans-l-[3- (dif]uoromethoxy)cyclobutyl]-5-methyl-pyrazol-4-amine and rranA”-l-[3-(di£luoromethox’)cyclobutyl]-3- methyl-pyrazol-4-amme as a brown oil. LCMS: RT 2.06 min, m/z ==393.1 |M+H]+. To a mixture of trans- 1 – f 3 -(difluoromethoxy )cyclobutyl] -5 -methyl -pyrazol -4-amine and trans- 1 – f 3 – (difluoromethoxy)cyclobutyl]-3-methyl-pyrazol-4-amine (270 mg, 1.24 mmol) in 1,4-dioxane (10 mL) was added 2~chloro-N-methy3-5~(trifliJoromethyi)pyrimidin-4-amine (262 mg, 1.24 mmol) and TsOH-H20 (236 mg, 1.24 mmol) at 15 C. The mixture was warmed to 90 C and stirred for 2 h. The reaction was quenched with H20 ( 1 mL), then concentrated under reduced pressure. The crude was purified by prep-HPLC (FA) to give trans-N2-[l-[3-(difluoromethoxy)cyclobutyl]-5-methyl-pyrazol-4-yl]-N4-methyl-5- (trifluoromethyl)pyrimidine-2,4-diamine (D-25): 1H NMR (400 MHz, CDC13): delta rhorhoiotaeta 8.08 (s, 1 H) 7.71 – 7.98 (br. s., 1 H), 6.23 (t, J =3.2 Hz, 1 H), 5 ,20 (t, .7 =3,2 Hz, 1 H), 4.1 (t, J =3.2 Hz, 1 H), 4 ,75 (br. s., 1 H), 3,03 (s, 3 H), 2.97 – 3.03 (m, 2 H), 2.68 – 2,73 (m, 2 H), 2,20 (s, 3 H); HPLC: RT 2.06 mm; MS: m/z: 393.1 [M+H]+ trans-N2-[l-[3-(difluoromethoxy)cyclobutyl]-3-methyl-pyrazol-4-yl]-]N4-methyl-5- (trifluoromethyl)pyrimidine-2,4-diamine (D-26): ‘H NMR (400 MHz, CDCi3): delta rhorhoetaiota 8.21 (s, 1 H), 8.07 (br, s,, 1 ). 7.89 (s, 1 H), 6,22 (t, J =3 ,2 Hz, I H), 5.34 (br. s., 1 H), 4.96-5.02 (m, 1 H), 4,81 – 4.90 (m, 1 H) 3.04 – 3.15 (m, 3 H), 2.84 – 2.96 (m, 2 H), 2.65 – 2.78 (m, 2 H), 2.31 (s, 3 H); HPLC: RT 2.06 min; MS: m/z: 393.1 j M 1 1 ] –
If you are interested in these compounds, you can also browse my other articles.Thank you for taking the time to read this article. I hope you enjoyed it.
Reference:
Patent; DENALI THERAPEUTICS INC.; ESTRADA, Anthony A.; FENG, Jianwen A.; LYSSIKATOS, Joseph P.; SWEENEY, Zachary K.; DE VICENTE FIDALGO, Javier; (271 pag.)WO2017/87905; (2017); A1;,
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics